I think the main issue is retail vs wholesale. (BGI’s $600 probably means volume pricing.) Also, I think NHGRI publishes averages over deployed machines, including old ones, which overestimates the cost of buying a new machine to create new capacity.
Dante is a retail commercial product of $700 for a whole genome. Dante and Veritas had previously had sales of $200 and $300 (which was probably measuring the demand curve and doesn’t say much about cost). Two days after writing this comment, Veritas cut its price in half to $600, below Dante.
I think the main issue is retail vs wholesale. (BGI’s $600 probably means volume pricing.) Also, I think NHGRI publishes averages over deployed machines, including old ones, which overestimates the cost of buying a new machine to create new capacity.
Dante is a retail commercial product of $700 for a whole genome. Dante and Veritas had previously had sales of $200 and $300 (which was probably measuring the demand curve and doesn’t say much about cost). Two days after writing this comment, Veritas cut its price in half to $600, below Dante.